GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (GREY:DCOIF) » Definitions » Scaled Net Operating Assets

Dicot AB (Dicot AB) Scaled Net Operating Assets : -0.02 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Dicot AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dicot AB's operating assets for the quarter that ended in Mar. 2024 was $0.63 Mil. Dicot AB's operating liabilities for the quarter that ended in Mar. 2024 was $0.75 Mil. Dicot AB's Total Assets for the quarter that ended in Dec. 2023 was $5.22 Mil. Therefore, Dicot AB's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was -0.02.


Dicot AB Scaled Net Operating Assets Historical Data

The historical data trend for Dicot AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB Scaled Net Operating Assets Chart

Dicot AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.06 -0.05 -0.08 -0.11 -0.24

Dicot AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.01 -0.01 -0.06 -0.02

Competitive Comparison of Dicot AB's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Dicot AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dicot AB's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dicot AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Dicot AB's Scaled Net Operating Assets falls into.



Dicot AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dicot AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(0.606-0.893)/1.192
=-0.24

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5.221 - 4.615
=0.606

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.893 - 0 - 0
=0.893

Dicot AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(0.631-0.753)/5.221
=-0.02

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3.707 - 3.076
=0.631

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.753 - 0 - 0
=0.753

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dicot AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Dicot AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Dicot AB (Dicot AB) Business Description

Industry
Traded in Other Exchanges
Address
Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37
Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (Dicot AB) Headlines

No Headlines